Abstract
Marfan syndrome in the neonatal age represents a severe early and commonly lethal manifestation of Marfan syndrome, which is caused by mutations in the gene encoding fibrillin-1 (FBN1). Here, we report a newborn with severe Marfan syndrome and a novel mutation involving cysteine substitution within one of the epidermal growth factor-like domains of FBN1.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006; 312 (5770): 117–121.
Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991; 352 (6333): 337–339.
Hennekam RC . Severe infantile Marfan syndrome versus neonatal Marfan syndrome. Am J Med Genet A 2005; 139 (1): 1.
Milewicz DM, Duvic M . Severe neonatal Marfan syndrome resulting from a de novo 3-bp insertion into the fibrillin gene on chromosome 15. Am J Hum Genet 1994; 54 (3): 447–453.
Robinson PN, Booms P, Katzke S, Ladewig M, Neumann L, Palz M et al. Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies. Hum Mutat 2002; 20 (3): 153–161.
Tiecke F, Katzke S, Booms P, Robinson PN, Neumann L, Godfrey M et al. Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype-phenotype correlations in FBN1 exons 24–40. Eur J Hum Genet 2001; 9 (1): 13–21.
Dietz HC, Pyeritz RE . Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Mol Genet 1995; 4 spec no.: 1799–1809.
Collod-Beroud G, Beroud C, Ades L, Black C, Boxer M, Brock DJ et al. Marfan database (third edition): new mutations and new routines for the software. Nucleic Acids Res 1998; 26 (1): 223–229.
Robinson PN, Arteaga-Solis E, Baldock C, Collod-Beroud G, Booms P, De Paepe A et al. The molecular genetics of Marfan syndrome and related disorders. J Med Genet 2006; 43 (10): 769–787.
Schrijver I, Liu W, Brenn T, Furthmayr H, Francke U . Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes. Am J Hum Genet 1999; 65 (4): 1007–1020.
Ng CM, Cheng A, Myers LA, Martinez-Murillo F, Jie C, Bedja D et al. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 2004; 114 (11): 1586–1592.
Author information
Authors and Affiliations
Corresponding author
Additional information
No funding provided and no conflict of interest.
Rights and permissions
About this article
Cite this article
Kochilas, L., Gundogan, F., Atalay, M. et al. A novel mutation of the fibrillin-1 gene in a newborn with severe Marfan syndrome. J Perinatol 28, 303–305 (2008). https://doi.org/10.1038/sj.jp.7211915
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7211915
Keywords
This article is cited by
-
Genotype-phenotype spectrum and prognosis of early-onset Marfan syndrome
BMC Pediatrics (2023)